Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGES | O14684 | 13/20 | 0.39 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.35 |
| ▸ | DRD3 | P35462 | 1/20 | 0.35 |
| ▸ | CTSL | P07711 | 1/20 | 0.35 |
| ▸ | CTSS | P25774 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26225717 | 1.00 | PTGES (0.39) | PTGESUSP30PTGS2ALDH1A1HTR2A | |
| SCHEMBL26225708 | 0.91 | USP30 (0.40) | PTGESUSP30PTGS2HTR2ADRD3 | |
| SCHEMBL24473738 | 0.90 | PTGES (0.43) | PTGESUSP30PTGS2HTR2ADRD3 | |
| SCHEMBL26225700 | 0.89 | PTGES (0.39) | PTGESUSP30PTGS2ALDH1A1POLB | |
| SCHEMBL26225689 | 0.82 | PTGES (0.46) | PTGESPTGS2 | |
| SCHEMBL26185597 | 0.82 | NPC1 (0.40) | ALDH1A1POLBKDM4EGLAKMT2A | |
| SCHEMBL29700392 | 0.82 | NPC1 (0.40) | ALDH1A1POLBKDM4EGLAKMT2A | |
| SCHEMBL24473771 | 0.81 | PTGES (0.46) | PTGESUSP30PTGS2HTR2ADRD3 | |
| SCHEMBL26225691 | 0.80 | PTGES (0.44) | PTGESPTGS2ALDH1A1KDM4E | |
| SCHEMBL29630913 | 0.80 | PTGES (0.50) | PTGESPTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116457352-A | Aryloxazolo spiro derivatives for the treatment and prophylaxis of hepatitis b virus infection | 豪夫迈·罗氏有限公司 | 2023-07-18 | — | — | CN | claimed |